Zobrazeno 1 - 10
of 121
pro vyhledávání: '"David W. H. Riches"'
Autor:
Daniel G Foster, Nomin Javkhlan, Jasmine Wilson, Benjamin L. Edelman, David W. H. Riches, Elizabeth F. Redente
Publikováno v:
Journal of Clinical and Translational Science, Vol 7, Pp 133-134 (2023)
OBJECTIVES/GOALS: Silicosis is a highly fatal progressive fibrotic disease of the lungs characterized by accumulation and persistence of fibroblasts that excessively deposit Collagen1a1. We sought to eliminate Collagen1a1-expressing fibroblasts throu
Externí odkaz:
https://doaj.org/article/5fc1681d4c9945b19ea82670e716be67
Autor:
Thomas Caracena, Rachel Blomberg, Rukshika S. Hewawasam, Zoe E. Fry, David W. H. Riches, Chelsea M. Magin
Publikováno v:
Biomaterials Science. 10:7133-7148
Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease that progressively and irreversibly alters the lung parenchyma, eventually leading to respiratory failure. The study of this disease has been historically challenging due to the myriad
Autor:
Kamiel S. Saleh, Rukshika Hewawasam, Predrag Šerbedžija, Rachel Blomberg, Saif E. Noreldeen, Benjamin Edelman, Bradford J. Smith, David W. H. Riches, Chelsea M. Magin
Publikováno v:
Cell Mol Bioeng
Idiopathic pulmonary fibrosis is a chronic disease characterized by progressive lung scarring that inhibits gas exchange. Evidence suggests fibroblast-matrix interactions are a prominent driver of disease. However, available preclinical models limit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::486ffa54c942d9eb467e02180088efa2
https://europepmc.org/articles/PMC9700547/
https://europepmc.org/articles/PMC9700547/
Autor:
Thomas R. Martin, Rachel L. Zemans, Lorraine B. Ware, Eric P. Schmidt, David W. H. Riches, Lisa Bastarache, Carolyn S. Calfee, Tushar J. Desai, Susanne Herold, Catherine L. Hough, Mark R. Looney, Michael A. Matthay, Nuala Meyer, Samir M. Parikh, Troy Stevens, B. Taylor Thompson
Publikováno v:
Am J Respir Cell Mol Biol
Clinical and molecular heterogeneity are common features of human disease. Understanding the basis for heterogeneity has led to major advances in therapy for many cancers and pulmonary diseases such as cystic fibrosis and asthma. Although heterogenei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::424cf0e8c152886ab2c922b76deecc79
https://europepmc.org/articles/PMC9447141/
https://europepmc.org/articles/PMC9447141/
Autor:
Ali N. Bahadur, Bart P. Black, David A. Lynch, Elizabeth F. Redente, David W. H. Riches, Rachel L. Zemans, Stephen M. Humphries, Donald S. Backos, Rubin M. Tuder
Publikováno v:
Am J Respir Cell Mol Biol
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic interstitial lung disease with underlying mechanisms that have been primarily investigated in mice after intratracheal instillation of a single dose of bleomycin. However, the model has si
Autor:
Bart P. Black, Max A. Seibold, Ben L. Edelman, Satria Sajuthi, Sangeeta Chakraborty, Elizabeth F. Redente, David W. H. Riches
Publikováno v:
JCI Insight, Vol 6, Iss 1 (2021)
JCI Insight
JCI Insight
Idiopathic pulmonary fibrosis (IPF) is a progressive, irreversible fibrotic disease of the distal lung alveoli that culminates in respiratory failure and reduced lifespan. Unlike normal lung repair in response to injury, IPF is associated with the ac
Autor:
Max A. Seibold, Sangeeta Chakraborty, Bart P. Black, Satria Sajuthi, Benjamin L. Edelman, Elizabeth F. Redente, David W. H. Riches
Idiopathic pulmonary fibrosis (IPF) is a progressive, irreversible fibrotic disease of the distal lung alveoli that culminates in respiratory failure and reduced lifespan. Unlike normal lung repair in response to injury, IPF is associated with the ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c86dca8e843f42cf2fe2c1323c73bab7
https://doi.org/10.1101/2020.08.18.255869
https://doi.org/10.1101/2020.08.18.255869
Autor:
David W. H. Riches, Andrew Thorburn, Alison Bamberg, Steve D. Groshong, Stijn De Langhe, Murry W. Wynes, Bart P. Black, Rubin M. Tuder, Luis A. Ortiz, Douglas Curran-Everett, Gregory P. Cosgrove, Elizabeth F. Redente, Rebecca C. Keith, Carlyne D. Cool, Benjamin L. Edelman
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 198:914-927
Idiopathic pulmonary fibrosis (IPF) is a progressive, fibrotic interstitial lung disease characterized by (myo)fibroblast accumulation and collagen deposition. Resistance to Fas-induced apoptosis is thought to facilitate (myo)fibroblast persistence i
Autor:
David W H, Riches, Thomas R, Martin
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1809
The nasal passages, conducting airways and gas-exchange surfaces of the lung, are constantly exposed to substances contained in the air that we breathe. While many of these suspended substances are relatively harmless, some, for example, pathogenic m
Autor:
David A. Lynch, Ali N. Bahadur, Elizabeth F. Redente, Stephen M. Humphries, Benjamin L. Edelman, Martin A. Aguilar, Bart P. Black, David W. H. Riches, Lutz Wollin
Rheumatoid arthritis (RA)-associated interstitial lung disease (RA-ILD) develops in ~20% of patients with RA. SKG mice, which are genetically prone to development of autoimmune arthritis, develop a pulmonary interstitial pneumonia that resembles huma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6289e875936b0dbbfa435b4778aaf74a
https://europepmc.org/articles/PMC6335004/
https://europepmc.org/articles/PMC6335004/